Evidence‐based safety profile of oral ketorolac in adults: Systematic review and meta‐analysis
Vicente Esparza‐Villalpando, Gladys Ortiz‐Barroso, David Masuoka‐Ito · 2024
Read Evidence‐based safety profile of oral ketorolac in adults: Systematic review and meta‐analysis by Vicente Esparza‐Villalpando, Gladys Ortiz‐Barroso, David Masuoka‐Ito (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11584978.txt.
Description
Vicente Esparza-Villalpando and co-authors weighed the safety of oral ketorolac in a 2024 review. Ketorolac is a strong pain drug taken by mouth, and doctors need a clear picture of its harms before choosing it over other options.
The team pooled 50 clinical trials and compared side effects across placebo and rival drugs. A single dose brought more adverse events than placebo, while repeated doses over one to ten days looked safer than active rivals. Doses of 5, 10, or 20 milligrams in multi-day courses did not raise risk in the pooled data. The review gives prescribers a trial-based map of when this painkiller's risks stay modest.
Catalog record
| CREATOR | Vicente Esparza‐Villalpando, Gladys Ortiz‐Barroso, David Masuoka‐Ito |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |